Avidity Biosciences (RNA) Earnings Date, Estimates & Call Transcripts $35.92 -0.79 (-2.15%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$36.44 +0.52 (+1.45%) As of 08/1/2025 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Avidity Biosciences Earnings Summary Avidity Biosciences posted Q1 2025 earnings on May 8, 2025, reporting an EPS of -$0.90, which missed analysts' consensus estimates of -$0.88 by $0.02. Quarterly revenue was reported to be $1.60 million, below the consensus estimate of $2.63 million. With a trailing EPS of -$3.00, Avidity Biosciences' earnings are expected to decrease next year, from ($2.89) to ($3.34) per share. Upcoming Q2 Earnings DateAug. 8Before Market OpensEstimatedConsensus EPS (May. 8) -$0.88 Actual EPS (May. 8) -$0.90 Missed By -$0.02 Actual Revenue (May. 8) $1.60MQ1 2025 Earnings ResourcesQ1 2025 Earnings Report Quarterly Report (10-Q) Press Release (8-K)RNA Upcoming EarningsAvidity Biosciences' Q2 2025 earnings is scheduled for Friday, August 8, 2025Powered by Get Avidity Biosciences Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Avidity Biosciences and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataRNA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.RNA Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Avidity Biosciences Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.88-$0.88-$0.88Q2 20252-$0.93-$0.61-$0.77Q3 20252-$0.99-$0.61-$0.80Q4 20252-$1.05-$0.61-$0.83 Avidity Biosciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/8/2025(Estimated)--------5/8/2025Q1 2025-$0.88-$0.90 -$0.02-$0.90$2.63M$1.60M2/27/2025Q4 2024-$0.76-$0.80 -$0.04-$0.80$1.74M$2.97M11/7/2024--$0.79-$0.65+$0.14-$0.65$7.09M$2.34M8/9/2024--$0.76-$0.65+$0.11-$0.65$7.09M$2.05M5/15/2024--$0.81-$0.79+$0.02-$0.79$7.09M$3.54M2/28/2024Q4 2023-$0.54-$0.79 -$0.25-$0.79$32.08M$2.19M11/8/2023Q3 2023-$0.76-$0.71+$0.05-$0.71$2.09M$2.82M8/8/2023Q2 2023-$0.84-$0.66+$0.18-$0.66$2.09M$2.32M Avidity Biosciences Earnings - Frequently Asked Questions When is Avidity Biosciences' earnings date? Avidity Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, August 8th, 2025 based off last year's report dates. Learn more on RNA's earnings history. Did Avidity Biosciences beat their earnings estimates last quarter? In the previous quarter, Avidity Biosciences (NASDAQ:RNA) missed the analysts' consensus estimate of ($0.88) by $0.02 with a reported earnings per share (EPS) of ($0.90). Learn more on analysts' earnings estimate vs. RNA's actual earnings. How much revenue does Avidity Biosciences generate each year? Avidity Biosciences (NASDAQ:RNA) has a recorded annual revenue of $10.90 million. How much profit does Avidity Biosciences generate each year? Avidity Biosciences (NASDAQ:RNA) has a recorded net income of -$322.30 million. RNA has generated -$3.00 earnings per share over the last four quarters. What is Avidity Biosciences' EPS forecast for next year? Avidity Biosciences' earnings are expected to decrease from ($2.89) per share to ($3.34) per share in the next year. More Earnings Resources from MarketBeat Related Companies Genmab A/S Earnings Results Moderna Earnings Results Dr. Reddy's Laboratories Earnings Results QIAGEN Earnings Results Viatris Earnings Results Ascendis Pharma A/S Earnings Results BridgeBio Pharma Earnings Results Verona Pharma PLC American Depositary Share Earnings Results Blueprint Medicines Earnings Results Legend Biotech Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Amazon's Earnings: What Comes Next and How to Play ItApple Stock: Big Earnings, Small Move—Time to Buy?Microsoft Blasts Past Earnings—What’s Next for MSFT?Visa Beats Q3 Earnings Expectations, So Why Did the Market Panic?Spotify's Q2 Earnings Plunge: An Opportunity or Ominous Signal?RCL Stock Sinks After Earnings—Is a Buying Opportunity Ahead?Amazon's Pre-Earnings Setup Is Almost Too Clean—Red Flag? This page (NASDAQ:RNA) was last updated on 8/4/2025 by MarketBeat.com Staff From Our PartnersWall Street Laughed. Now They're Buying.For six months, I’ve been pounding the table on a major gold miner—while Twitter pundits laughed. But now, the...Golden Portfolio | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredOut with the old (A.I.) - In with the new (E.I.)One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avidity Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avidity Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
